Pharma company Influence Medical Education Promotes OffLabel Use of Antipsychotic
Psychiatry’s professional practice paradigm has received a major blow.
-
-
CATIE study results Contradict Current Clinical Practice & Treatment Guidelines
Newly published results (phase II) from the CATIE schizophrenia treatment efficacy study sponsored by the National Institute of Mental Health comparing the most commonly used second generation drug treatments for schizophrenia and depression, is highly disturbing.
-
An Out of Control Profession_NewScientist / Infant Mental Health Now Targeted by Psychiatry_MSNBC
A report in The New Scientist, "Prescribing of Hyperactivity Drugs is Out of Control," shows just how deviant U.S. prescribing of psychostimulants for
children is compared to the rest of the world. -
Psychiatry’s “Desperate Cures?” Electric Switches for Depression?
An OpEd in The New York Times (below) is trumpeting psychiatry’s latest “cure” for depression: it requires surgical implantation of electrodes in the brain, continued “maintenance” with powerful psychotropic drugs, and it costs $40,000.
-
Carefully Weigh Drug Firms’ Claims
The truth about the pharmaceutical industry and its corrupting influence on high ranking lawmakers and the near-total subversion of the FDA is spreading to the American hinterland. Below is an informed, intelligent editorial in the Shreveport Times, Louisiana that explains to readers why this industry is not to be trusted.
-
Pills Become Addictive Study Aid For Students (Adderall)
Amphetamines work like Cocaine–first and foremost, they are addictive. The psychostimulant drugs prescribed for millions of American children labeled ADHD, are amphetamines and are, therefore, addictive.
-
FDA Staff Travels on Drug Industry Dollars
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
-
Are Drugs Always Needed for Schizophrenia? What does the Scientific Evidence Show?
“Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?” An article in the Schizophrenia Bulletin, by Dr. John Bola that dares to question the validity of the unexamined treatment paradigm in schizophrenia:
-
DAWN: “Disposition of Emergency Department Visits for Drug-Related Suicide Attempts by Adolescents:
A report by the Drug Abuse Warning Network (DAWN), reveals some sobering facts about teenage suicide attempts that involve drugs.
-
Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow
Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency.
-
Addictive Qualities of Modafinil Not Discussed by FDA Advisory
The focus of a recent FDA’s Psychopharmacology Advisory Committee meeting, was the drug, modafinil (as Sparlon), for ADHD and the risk of
Steven-Johnson’s, a rare but potentially fatal, skin condition. -
“Some of the children were prescribed anti-psychotics, rather than discontinued from ADHD therapy.”
"That thing I’m worried about…where the MedGuide would help, where it might even warrant a black box, if this is common, where somebody hallucinates and then gets put on an anti-psychotic drug. That would really be something worth making sure it doesn’t happen,"